Disc Medicine (IRON) Treasury Shares (2020 - 2022)

Disc Medicine (IRON) has reported Treasury Shares for 6 consecutive years, with $1.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Treasury Shares rose 140.44% year-over-year to $1.1 million; the TTM figure through Dec 2025 stood at $1.1 million (up 140.44% YoY), while the FY2025 annual figure was $1.1 million, up 140.44% from the prior year.
• Treasury Shares rose to $1.1 million in Q4 2025 per IRON's latest filing, from $475140.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $41.7 million in Q1 2022 and bottomed at $958.0 in Q1 2023.
• Historically, Treasury Shares has averaged $14.1 million across 5 years, with a median of $475140.0 in 2024.
• Annual changes were most pronounced in 2023 — Treasury Shares sank 100.0% — and 2025, when it surged 140.44%.
• Disc Medicine's Treasury Shares stood at $10170.0 in 2021, then plunged by 81.16% to $1916.0 in 2022, then slumped by 50.0% to $958.0 in 2023, then jumped by 49497.08% to $475140.0 in 2024, then surged by 140.44% to $1.1 million in 2025.
• Business Quant data shows IRON's Treasury Shares at $1.1 million in Q4 2025, $475140.0 in Q4 2024, and $429522.0 in Q3 2024.